OA11213A - Cox-2 selective carprofen for treating pain and inflammation in dogs - Google Patents

Cox-2 selective carprofen for treating pain and inflammation in dogs Download PDF

Info

Publication number: OA11213A
Authority: OA; OAPI
Prior art keywords: cox; carprofen; inhibitors; inhibitor; inhibition
Prior art date: 1997-05-05

Application number

OA9900242A

Other languages

English (en)

Inventor

Kristin Marie Lundy

Anthony Paul Ricketts

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-05

Filing date

1999-11-02

Publication date

2003-07-14

1999-11-02 Application filed by Pfizer filed Critical Pfizer

2003-07-14 Publication of OA11213A publication Critical patent/OA11213A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Medicinal Preparation (AREA)

OA9900242A 1997-05-05 1999-11-02 Cox-2 selective carprofen for treating pain and inflammation in dogs OA11213A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US4563597P	1997-05-05	1997-05-05

Publications (1)

Publication Number	Publication Date
OA11213A true OA11213A (en)	2003-07-14

Family

ID=21939053

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA9900242A OA11213A (en)	1997-05-05	1999-11-02	Cox-2 selective carprofen for treating pain and inflammation in dogs

Country Status (32)

Country	Link
EP (1)	EP0988034A1 (es)
JP (1)	JP2000513020A (es)
KR (2)	KR20010012300A (es)
CN (1)	CN1255059A (es)
AP (1)	AP9801234A0 (es)
AR (2)	AR011726A1 (es)
AU (1)	AU6932198A (es)
BG (1)	BG103852A (es)
BR (1)	BR9808720A (es)
CA (1)	CA2288759A1 (es)
DZ (1)	DZ2479A1 (es)
EA (1)	EA003696B1 (es)
GT (1)	GT199800063A (es)
HR (1)	HRP980244A2 (es)
HU (1)	HUP0001286A3 (es)
ID (1)	ID21311A (es)
IL (1)	IL132570A0 (es)
IS (1)	IS5220A (es)
MA (1)	MA26491A1 (es)
NO (1)	NO995389L (es)
NZ (1)	NZ500183A (es)
OA (1)	OA11213A (es)
PA (1)	PA8450601A1 (es)
PE (1)	PE72599A1 (es)
PL (1)	PL337003A1 (es)
SK (1)	SK148199A3 (es)
TN (1)	TNSN98059A1 (es)
TW (1)	TW590773B (es)
UY (1)	UY24989A1 (es)
WO (1)	WO1998050033A1 (es)
YU (1)	YU55899A (es)
ZA (1)	ZA983722B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6245797B1 (en)	1997-10-22	2001-06-12	Merck & Co., Inc.	Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6506785B2 (en) *	1998-05-22	2003-01-14	Pfizer, Inc.	Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU2003204888B2 (en) *	1998-05-22	2005-07-28	Pfizer Products Inc.	Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
EP1123091A1 (en) *	1998-10-23	2001-08-16	Merck Frosst Canada & Co.	Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
EP1637137A3 (en) *	1999-03-10	2006-07-05	G.D. Searle LLC	Method and composition for administering a cyclooxygenase-2 inhibitor to animals
WO2001034204A1 (en) *	1999-11-11	2001-05-17	Eli Lilly And Company	Oncolytic combinations for the treatment of cancer
JP2004521856A (ja) *	2000-05-15	2004-07-22	メルクフロストカナダアンドカンパニー	Ｃｏｘ−２選択的阻害剤およびトロンボキサン阻害剤を用いる併用療法ならびにそのための組成物
CA2411960C (en)	2000-06-13	2010-10-12	Wyeth	Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
DE10032132A1 (de) *	2000-07-01	2002-01-17	Lohmann Therapie Syst Lts	Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
EP1307538B1 (en)	2000-08-07	2009-01-07	Vanderbilt University	Detection of cox-2 activity and anandamide metabolites
WO2003007875A2 (en) *	2001-07-16	2003-01-30	Hoegestaett Edward	Compounds with analgesic, antipyretic and/or anti-inflammatory activity
DK1534305T3 (da)	2003-05-07	2007-02-05	Osteologix As	Behandling af brusk-/knoglelidelser med vandoplöselige strontiumsalte
CA2533101A1 (en) *	2003-07-31	2005-02-03	Pharmacia & Upjohn Company Llc	Dispersible formulation of an anti-inflammatory agent
US20080269310A1 (en) *	2005-05-20	2008-10-30	Adrian Paul Foster	Synergistic Combinations
DK2079456T3 (da)	2007-04-04	2013-03-18	Sigmoid Pharma Ltd	Farmaceutiske cyclosporinsammensætninger
EP2061587A1 (en)	2007-04-26	2009-05-27	Sigmoid Pharma Limited	Manufacture of multiple minicapsules
BRPI1012196B1 (pt)	2009-05-18	2021-11-30	Sublimity Therapeutics Limited	Composição compreendendo gotas de óleo
EP2464341B1 (en)	2009-08-12	2022-07-06	Sublimity Therapeutics Limited	Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en)	2010-11-25	2011-01-12	Sigmoid Pharma Ltd	Composition
GB201212010D0 (en)	2012-07-05	2012-08-22	Sigmoid Pharma Ltd	Formulations
GB201319791D0 (en)	2013-11-08	2013-12-25	Sigmoid Pharma Ltd	Formulations
ES2907285T3 (es)	2014-03-06	2022-04-22	Elanco Animal Health Incorporated	Composiciones de grapiprant y procedimientos de uso de las mismas
US12109218B2 (en)	2014-12-09	2024-10-08	Aratana Therapeutics, Inc.	Compositions of grapiprant and methods for using the same
KR20170102223A (ko)	2014-11-07	2017-09-08	시그모이드 파마 리미티드	사이클로스포린을 포함하는 조성물
CA2972996A1 (en) *	2015-01-09	2016-07-14	Jaguar Animal Health	Methods of treating diarrhea in companion animals
EP4125874A4 (en) *	2020-03-25	2024-05-01	SRI International	LIPOXYGENASE INHIBITORS
US11116737B1 (en)	2020-04-10	2021-09-14	University Of Georgia Research Foundation, Inc.	Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko)	2020-11-30	2022-06-07	(주)이노보테라퓨틱스	벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3896145A (en) *	1972-07-24	1975-07-22	Hoffmann La Roche	Carbazoles
CA1319886C (en) *	1987-02-03	1993-07-06	Alberto Ferro	Mixed micelle solutions

1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/xx active
- 1998-04-30 TW TW087106689A patent/TW590773B/zh not_active IP Right Cessation
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/ko not_active Application Discontinuation
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/pt not_active IP Right Cessation
- 1998-05-01 EA EA199900895A patent/EA003696B1/ru not_active IP Right Cessation
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/hu unknown
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/ko not_active Application Discontinuation
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 IL IL13257098A patent/IL132570A0/xx unknown
- 1998-05-01 PL PL98337003A patent/PL337003A1/xx unknown
- 1998-05-01 JP JP10547869A patent/JP2000513020A/ja active Pending
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/en not_active Application Discontinuation
- 1998-05-01 CN CN98804845A patent/CN1255059A/zh active Pending
- 1998-05-01 SK SK1481-99A patent/SK148199A3/sk unknown
- 1998-05-01 ID IDP980651A patent/ID21311A/id unknown
- 1998-05-01 EP EP98915041A patent/EP0988034A1/en not_active Withdrawn
- 1998-05-01 CA CA002288759A patent/CA2288759A1/en not_active Abandoned
- 1998-05-01 YU YU55899A patent/YU55899A/sh unknown
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/xx unknown
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/fr unknown
- 1998-05-04 UY UY24989A patent/UY24989A1/es not_active Application Discontinuation
- 1998-05-04 PE PE1998000335A patent/PE72599A1/es not_active Application Discontinuation
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-04 MA MA25059A patent/MA26491A1/fr unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/es unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/hr not_active Application Discontinuation
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/es unknown
- 1998-05-05 AR ARP980102089A patent/AR011726A1/es unknown
1999
- 1999-10-19 IS IS5220A patent/IS5220A/is unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/xx unknown
- 1999-11-04 NO NO995389A patent/NO995389L/no not_active Application Discontinuation
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/es unknown

Also Published As

Publication number	Publication date
EA003696B1 (ru)	2003-08-28
ID21311A (id)	1999-05-20
HUP0001286A2 (hu)	2000-11-28
YU55899A (sh)	2003-08-29
DZ2479A1 (fr)	2003-02-01
AP9801234A0 (en)	1999-11-04
WO1998050033A1 (en)	1998-11-12
IL132570A0 (en)	2001-03-19
MA26491A1 (fr)	2004-12-20
HUP0001286A3 (en)	2000-12-28
PL337003A1 (en)	2000-07-31
JP2000513020A (ja)	2000-10-03
UY24989A1 (es)	2001-10-25
TNSN98059A1 (fr)	2005-03-15
IS5220A (is)	1999-10-19
BG103852A (en)	2000-06-30
PA8450601A1 (es)	2000-05-24
ZA983722B (en)	1999-11-04
PE72599A1 (es)	1999-08-12
NO995389L (no)	2000-01-04
EA199900895A1 (ru)	2000-06-26
KR20010012300A (ko)	2001-02-15
NO995389D0 (no)	1999-11-04
AU6932198A (en)	1998-11-27
CN1255059A (zh)	2000-05-31
TW590773B (en)	2004-06-11
BR9808720A (pt)	2000-07-11
AR039628A2 (es)	2005-03-02
AR011726A1 (es)	2000-08-30
SK148199A3 (en)	2001-09-11
HRP980244A2 (en)	1999-02-28
EP0988034A1 (en)	2000-03-29
NZ500183A (en)	2002-04-26
CA2288759A1 (en)	1998-11-12
GT199800063A (es)	1999-10-26
KR20040004406A (ko)	2004-01-13

Publication	Publication Date	Title
OA11213A (en)	2003-07-14	Cox-2 selective carprofen for treating pain and inflammation in dogs
TWI268925B (en)	2006-12-21	5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
US6399647B2 (en)	2002-06-04	Amide derivatives for antiangiogenic and/or antitumorigenic use
KR101890442B1 (ko)	2018-08-21	Ｐ2ｘ4 수용체 길항제
BR112013000783B1 (pt)	2022-01-25	Derivados arilamídicos apresentando propriedades antiandrogênicas, seu processo de preparação, e composição farmacêutica
JP2003530438A (ja)	2003-10-14	化合物および方法
US6878733B1 (en)	2005-04-12	Formulations for pharmaceutical agents ionizable as free acids or free bases
TW201002311A (en)	2010-01-16	Novel compositions and methods for treating hyperproliferative diseases
US20030212123A1 (en)	2003-11-13	COX-2 selective carprofen for treating pain and inflammation in dogs
JP2003502367A (ja)	2003-01-21	インドール化合物
HU230250B1 (hu)	2015-11-30	Piperazinilkarbonilkinolinok és -izokinolinok
CN101563321B (zh)	2012-05-30	4-(杂环基)烷基-n-(芳基磺酰基)吲哚化合物及其作为5-ht6配体的用途
AU773615B2 (en)	2004-05-27	COX-2 selective carprofen for treating pain and inflammation in dogs
JP4662979B2 (ja)	2011-03-30	新規なβ−アゴニスト、その製造方法及びその薬物としての使用
AU2016377785B2 (en)	2021-07-01	CFTR regulators and methods of use thereof
US9079876B2 (en)	2015-07-14	Imidazole derivatives and preparation method and use thereof
NZ516914A (en)	2003-08-29	Compositions containing COX-2 selective carprofen and derivatives thereof for treating pain and inflammation in dogs
TW200826932A (en)	2008-07-01	Semi-solid formulations of phospholipase enzyme inhibitors
CZ9903896A3 (cs)	2001-05-16	Léčivo, farmaceutický přípravek a souprava pro léčení nebo prevenci bolesti a zánětlivých procesů
ZA200410123B (en)	2006-07-26	Annelated pyrrole compounds as proton pump inhibitors for treating ulcer
JPH072737B2 (ja)	1995-01-18	５−リポキシゲナ−ゼ経路の抑制
FR2565588A1 (fr)	1985-12-13	Produits pharmaceutiques cardio-actifs, en particulier anti-arythmiques, a base de composes triaminoarylpteridiniques
JPH0770083A (ja)	1995-03-14	イミダゾール誘導体を有効成分とする血圧降下剤
TW200908964A (en)	2009-03-01	Use of HDAC inhibitors for the treatment of gastrointestinal cancers
CN101528734B (zh)	2013-02-13	治疗代谢障碍的3-氨基吡啶衍生物